Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary BioScrip To Host Second Quarter Results Call
DENVER , July 17, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will release its second quarter 2017 financial results on Tuesday, August
Toggle Summary BioScrip Announces New Senior Note Facilities
Agreement Will Immediately Improve Capital Structure, Provide Operational Flexibility, and Result in Excess of $50 million in Liquidity DENVER , June 29, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and
Toggle Summary BioScrip Provides Update on UnitedHealthcare Contract
DENVER , May 30, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company has reached an agreement to continue to provide certain core product lines
Toggle Summary BioScrip to Present at the Jefferies 2017 Global Healthcare Conference
DENVER , May 24, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen M.
Toggle Summary BioScrip Reports First Quarter 2017 Financial Results
Q1 Consolidated Revenue of $217.8 Million, loss from continuing operations net of income taxes of $19.0 million and Adjusted EBITDA of $5.2 Million DENVER , May 04, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced its first quarter 2017 financial
Toggle Summary BioScrip Announces CFO Transition
Appoints Stephen M. Deitsch as Senior Vice President, Chief Financial Officer and Treasurer DENVER , April 20, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced the
Toggle Summary BioScrip To Host First Quarter 2017 Results Call
DENVER , April 17, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its first quarter 2017 financial results on Thursday, May 4, 2017 , before the opening of the U.S. financial markets. Daniel E. Greenleaf , President and Chief Executive Officer,
Toggle Summary BioScrip Announces Meeting with Investors
Company Expects Improved Profitability Following Termination of Agreement with UnitedHealthcare DENVER , March 27, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced members
Toggle Summary BioScrip Reports Fourth Quarter and Full-Year 2016 Financial Results
Q4 Consolidated Revenue of $240.1 Million, loss from continuing operations net of income taxes of ($5.2) million and Adjusted EBITDA of $9.5 Million DENVER , March 03, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced its fourth quarter and
Toggle Summary BioScrip Raises Approximately $5 million in Private Placement of Common Stock
DENVER , March 02, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that it entered into a Stock Purchase Agreement on March 1, 2017 , for the sale of an aggregate of